XML 125 R106.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share based compensation - Share options activities (Details)
$ / shares in Units, ¥ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
CNY (¥)
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
CNY (¥)
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
CNY (¥)
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Nov. 30, 2023
CNY (¥)
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Number of options:                      
Outstanding number of shares at beginning 1,739,000 1,739,000 2,512,000 2,512,000 4,526,000 4,526,000          
Granted 1,482,000 1,482,000 1,147,000 1,147,000 1,048,000 1,048,000          
Exercised (622,000) (622,000) (1,580,000) (1,580,000) (1,774,000) (1,774,000)          
Forfeited (311,000) (311,000) (340,000) (340,000) (1,288,000) (1,288,000)          
Outstanding number of shares at ending 2,288,000 2,288,000 1,739,000 1,739,000 2,512,000 2,512,000 4,526,000        
Options, vested and exercisable 1,140,000   846,000   1,116,000     1,140,000   846,000 1,116,000
Weighted Average Exercise Price:                      
Weighted average exercise price at beginning | $ / shares   $ 0.10   $ 0.10   $ 0.10          
Granted | $ / shares   0.01   0.10   0.10          
Exercised | $ / shares   0.03   0.10   0.10          
Forfeited | $ / shares   0.04   0.10   0.10          
Weighted average exercise price at ending | $ / shares   $ 0.01   $ 0.10   $ 0.10 $ 0.10        
Weighted average exercise price, vested and exercisable | $ / shares               $ 0.01   $ 0.10 $ 0.10
Weighted Average Remaining Contractual Term and Aggregate Intrinsic Value:                      
Weighted average contractual term outstanding 8 years 5 months 12 days 8 years 5 months 12 days 8 years 3 months 3 days 8 years 3 months 3 days 8 years 5 months 19 days 8 years 5 months 19 days 8 years 7 months 6 days        
Weighted average contractual term, vested and exercisable 7 years 7 months 28 days 7 years 7 months 28 days 7 years 6 months 21 days 7 years 6 months 21 days 8 years 10 months 2 days 8 years 10 months 2 days          
Aggregate intrinsic value outstanding | $             $ 66,255 $ 3,814   $ 2,742 $ 10,167
Aggregate intrinsic value exercised | $   $ 1,357   $ 2,193   $ 16,088          
Aggregate intrinsic value, vested and exercisable | $               $ 1,900   $ 1,334 $ 4,515
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]                      
Weighted average grant date fair value of options granted | $ / shares   $ 3.00   $ 4.42   $ 7.59          
Options granted 1,482,000 1,482,000 1,147,000 1,147,000 1,048,000 1,048,000          
Grant date fair value of options vested | ¥ ¥ 27,065   ¥ 74,266   ¥ 141,845            
Total unrecognized compensation expenses | ¥ ¥ 14,778   ¥ 26,733   ¥ 65,122            
Unrecognized compensation cost expected to be recognized over a weighted average period 1 year 6 months 7 days 1 year 6 months 7 days 1 year 5 months 19 days 1 year 5 months 19 days 2 years 1 month 17 days 2 years 1 month 17 days          
Second Amended 2018 Plan                      
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]                      
Number of shares available for future grant 560,144             560,144      
Plan 2021                      
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]                      
Total unrecognized compensation expenses | ¥                 ¥ 31,681